The purpose of this study is to evaluate patient setup accuracy and quantify individual and cumulative positioning uncertainties associated with different hardware and software components of the stereotactic radiotherapy (SRS/SRT) with the frameless 6D ExacTrac system. A statistical model is used to evaluate positioning uncertainties of the different components of SRS/SRT treatment with the Brainlab 6D ExacTrac system using the positioning shifts of 35 patients having cranial lesions. All these patients are immobilized with rigid head‐and‐neck masks, simulated with Brainlab localizer and planned with iPlan treatment planning system. Stereoscopic X‐ray images (XC) are acquired and registered to corresponding digitally reconstructed radiographs using bony‐anatomy matching to calculate 6D translational and rotational shifts. When the shifts are within tolerance (0.7 mm and 1°), treatment is initiated. Otherwise corrections are applied and additional X‐rays (XV) are acquired to verify that patient position is within tolerance. The uncertainties from the mask, localizer, IR ‐frame, X‐ray imaging, MV, and kV isocentricity are quantified individually. Mask uncertainty (translational: lateral, longitudinal, vertical; rotational: pitch, roll, yaw) is the largest and varies with patients in the range false(−2.07−3.71mm,−5.82−5.62mm,−5.84−3.61mm;−2.10−2.40∘,−2.23−2.60∘,and−2.7−3.00∘false) obtained from mean of XC shifts for each patient. Setup uncertainty in IR positioning (0.88, 2.12, 1.40 mm, and 0.64°, 0.83°, 0.96°) is extracted from standard deviation of XC. Systematic uncertainties of the frame (0.18, 0.25, −1.27mm, −0.32∘, 0.18°, and 0.47°) and localizer (−0.03, −0.01, 0.03 mm, and −0.03∘, 0.00°, −0.01∘) are extracted from means of all XV setups and mean of all XC distributions, respectively. Uncertainties in isocentricity of the MV radiotherapy machine are (0.27, 0.24, 0.34 mm) and kV imager (0.15, −0.4, 0.21 mm). A statistical model is developed to evaluate the individual and cumulative systematic and random positioning uncertainties induced by the different hardware and software components of the 6D ExacTrac system. The uncertainties from the mask, localizer, IR frame, X‐ray imaging, couch, MV linac, and kV imager isocentricity are quantified using statistical modeling.PACS number(s): 87.56.B‐, 87.59.B‐
The purpose of this study is to investigate an effect of angular dependence and calibration field size of MapCHECK 2 on RapidArc QA for 6, 8, 10, and 15 MV The angular dependence was investigated by comparing MapCHECK 2 measurements in MapPHAN‐MC2 to the corresponding Eclipse calculations every 10° using 10 × 10 cm2 and 3 × 3 cm2 fields. Fourteen patients were selected to make RapidArc plans using the four energies, and verification plans were delivered to two phantom setups: MapCHECK 2/MapPHAN phantom (MapPHAN QA) and MapCHECK 2 on an isocentric mounting fixture (IMF QA). Migration of MapCHECK 2 on IMF was simulated by splitting arcs every 10° and displacing an isocenter of each partial arc in the Eclipse system (IMFACTUAL QA). To investigate the effect of calibration field size, MapCHECK 2 was calibrated by two field sizes (10 × 10 cm2 and 3 × 3 cm2) and applied to all QA measurements. The γ test was implemented using criteria of 1%/1 mm, 2%/2 mm, and 3%/3 mm. A mean dose of all compared points for each plan was compared with respect to a mean effective field size of the RapidArc plan. The angular dependence was considerably high at gantry angles of 90° ± 10° and 270° ± 10° (for 10 × 10/3 × 3 cm2 at 90°, 30.6% ± 6.6%/33.4%± 5.8% (6 MV), 17.3% ± 5.3%/15.0% ± 6.8% (8 MV), 8.9% ± 2.9%/7.8% ± 3.2% (10 MV), and 2.2% ± 2.3%/‐1.3% ± 2.6% (15 MV)). For 6 MV, the angular dependence significantly deteriorated the γ passing rate for plans of large field size in MapPHAN QA (< 90% using 3%/3 mm); however, these plans passed the γ test in IMFACTUAL QA (> 95%). The different calibration field sizes did not make any significant dose difference for both MapPHAN QA and IMFACTUAL QA. For 8, 10, and 15 MV, the angular dependence does not make any clinically meaningful impact on MapPHAN QA. Both MapPHAN QA and IMFACTUAL QA presented clinically acceptable γ passing rates using 3%/3 mm. MapPHAN QA showed better passing rates than IMFACTUAL QA for the tighter criteria. The 10 × 10 cm2 calibration showed better agreement for plans of small effective field size (< 5 × 5 cm2) in MapPHAN QA. There was no statistical difference between IMF QA and IMFACTUAL QA. In conclusion, MapPHAN QA is not recommended for plans of large field size, especially for 6 MV, and MapCHECK 2 should be calibrated using a field size similar to a mean effective field size of a RapidArc plan for better agreement for IMF QA.PACS numbers: 87.55.km, 87.55.Qr, 87.56.Fc
Recent studies have reported about the application of volumetric-modulated arc radiotherapy in the treatment of multiple brain metastases. One of the key concerns for these radiosurgical treatments lies in the integral dose within the normal brain tissue, as it has been shown to increase with increasing number of brain tumors treated. In this study, we investigate the potential to improve normal brain tissue sparing specific to volumetric-modulated arc radiotherapy by increasing the number of isocenters and arc beams. Adopting a multi-institutional benchmark study protocol of planning multiple brain metastases via a radiosurgical apparatus, a flattening filter-free TrueBeam RapidArc delivery system (Varian Oncology, Palo Alto, California) was used for a volumetric-modulated arc radiotherapy treatment planning study, where treatment plans for target combinations of N ¼ 1, 3, 6, 9, and 12 targets were developed with increasing numbers of isocenters and arc beams. The treatment plans for each target combination were compared dosimetrically among each other and against the reference Gamma Knife treatment plan from the original benchmark study. We observed that as the number of isocenters or arc beams increased, the normal brain isodose volumes such as 12-to 4-Gy on average decreased by up to 15% for all the studied cases. However, when the best volumetric-modulated arc radiotherapy normal brain isodose volumes were compared against the corresponding reference Gamma Knife values, volumetric-modulated arc radiotherapy remained 100% to 200% higher than those of Gamma Knife for all target combinations. The study results, particularly for the solitary (N ¼ 1) metastases case, directly challenged the general notion of dose equivalence among current radiosurgical modalities. In conclusion, multiple isocenter and multiple arc beam delivery solutions are capable of decreasing normal brain irradiation exposure for volumetric-modulated arc radiotherapy. However, there is further technological development in need for volumetric-modulated arc radiotherapy before similar dosimetric treatment plans could be achievable when compared to Gamma Knife radiosurgery.
The purpose of this study is to determine comparability of three different planar IMRT QA techniques: patient gantry angle composite (PGAC), single gantry angle composite (SGAC), and field by field (FBF), using MapCHECK 2 device and the γ test as performance metrics; and to assess the dependency of these techniques on intensity modulation, couch attenuation, and detector position (angular dependency). Ten highly modulated head and neck (H&N) and ten moderately modulated prostate IMRT validation plans were delivered using different techniques and were intercompared using the Student's t‐test. The IMRT QA measurements were evaluated by percentage of points passing the γ test for three different criteria: 1% (dose difference)/1 mm (distance to agreement (DTA)) (C1), 2%/2 mm (C2), and 3%/3 mm (C3). To investigate dependency of the IMRT validation on treatment couch, ionization chamber measurements, as well as the conventional MapCHECK 2 QAs, were performed with PGAC and PGAC‐WOC (without couch; using an extended tennis racket‐type insert with negligible attenuation assumed). To determine angular dependency of the MapCHECK 2, patient gantry field‐by‐field (PG‐FBF) technique was delivered and evaluated separately for each field. The differences of γ passing rates between SGAC and FBF were statistically insignificant, while these were statistically significant when compared to PGAC. SGAC and FBF techniques showed statistically insignificant differences between different levels of intensity modulation (H&N vs. Prostate) at C2 and C3 criteria, while PGAC could not for any criteria. The treatment couch has a significant impact on γ passing rates (PGAC vs. PGAC‐WOC), but an ionization chamber‐based IMRT validations showed clinically insignificant dose errors (< 2%) in all cases. This study showed that the MapCHECK 2 device has large angular dependency, especially at gantry angles of 90° and 270°, which dramatically affected the γ passing rates of PGAC. With proper consideration of couch attenuation and beam arrangement, the MapCHECK 2 will produce clinically comparable QA results using the three different planar IMRT QA techniques.PACS numbers: 87.55.km, 87.55.Qr, 87.56.Fc
Dosimetric consequences of positional shifts were studied using frameless Brainlab ExacTrac X‐ray system for hypofractionated (3 or 5 fractions) intracranial stereotactic radiotherapy (SRT). SRT treatments of 17 patients with metastatic intracranial tumors using the stereotactic system were retrospectively investigated. The treatments were simulated in a treatment planning system by modifying planning parameters with a matrix conversion technique based on positional shifts for initial infrared (IR)‐based setup (XC: X‐ray correction) and post‐correction (XV: X‐ray verification). The simulation was implemented with (a) 3D translational shifts only and (b) 6D translational and rotational shifts for dosimetric effects of angular correction. Mean translations and rotations (± 1 SD) of 77 fractions based on the initial IR setup (XC) were 0.51±0.86 mm (lateral), 0.30±1.55 mm (longitudinal), and −1.63±1.00 mm (vertical); 0.53±0.56 mm (pitch), 0.42±0.60 mm (roll), and 0.44±0.90 mm (yaw), respectively. These were −0.07±0.24 mm, −0.07±0.25 mm, 0.06±0.21 mm, 0.04±0.23 mm, 0.00±0.30 mm, and 0.02±0.22 mm, respectively, for the postcorrection (XV). Substantial degradation of the treatment plans was observed in D95 of PTV (2.6%±3.3%; simulated treatment versus treatment planning), Dmin of PTV (13.4%±11.6%), and Dmin of CTV (2.8%±3.8%, with the maximum error of 10.0%) from XC, while dosimetrically negligible changes (< 0.1%) were detected for both CTV and PTV from XV simulation. 3D angular correction significantly improved CTV dose coverage when the total angular shifts (|pitch|+|roll|+|yaw|) were greater than 2°. With the 6D stereoscopic X‐ray verification imaging and frameless immobilization, submillimeter and subdegree accuracy is achieved with negligible dosimetric deviations. 3D angular correction is required when the angular deviation is substantial. A CTV‐to‐PTV safety margin of 2 mm is large enough to prevent deterioration of CTV coverage.PACS number: 87.55.dk
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.